| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS44032405 | HTLV-1 | ENSG00000131203.13 | protein_coding | IDO1 | No | No | 3620 | P14902 |
| TVIS44045934 | HTLV-1 | ENSG00000131203.13 | protein_coding | IDO1 | No | No | 3620 | P14902 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | IDO1 |
|---|---|
| DrugBank ID | DB00435 |
| Drug Name | Nitric Oxide |
| Target ID | BE0000693 |
| UniProt ID | P14902 |
| Regulation Type | |
| PubMed IDs | 16834326 |
| Citations | Samelson-Jones BJ, Yeh SR: Interactions between nitric oxide and indoleamine 2,3-dioxygenase. Biochemistry. 2006 Jul 18;45(28):8527-38. |
| Groups | Approved |
| Direct Classification | Other non-metal oxides |
| SMILES | [N]=O |
| Pathways | Hyperornithinemia-Hyperammonemia-Homocitrullinuria [HHH-syndrome]; Ornithine Aminotransferase Deficiency (OAT Deficiency); Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); Hyperprolinemia Type I; Hyperprolinemia Type II; Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency); Prolidase Deficiency (PD); Nitric Oxide Signaling Pathway; Arginine and Proline Metabolism; Hyperornithinemia with Gyrate Atrophy (HOGA); Prolinemia Type II; L-Arginine:Glycine Amidinotransferase Deficiency; Creatine Deficiency, Guanidinoacetate Methyltransferase Deficiency |
| PharmGKB | PA450635 |
| ChEMBL | CHEMBL1200689 |
